Warfarin or novel oral anticoagulants for atrial fibrillation

G. Y. H. Lip, Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary. Journal of Thrombosis and Haemostasis. ,vol. 11, pp. 615- 626 ,(2013) , 10.1111/JTH.12140

Torben Larsen, Lars Rasmussen, Flemming Skjøth, Indirect comparison studies--are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation. Thrombosis and Haemostasis. ,vol. 108, pp. 405- 406 ,(2012) , 10.1160/TH12-06-0438

Arlene Gallagher, Efrosini Setakis, Jonathan Plumb, Andreas Clemens, Tjeerd-Pieter van Staa, Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thrombosis and Haemostasis. ,vol. 106, pp. 968- 977 ,(2011) , 10.1160/TH11-05-0353

Authors/Task Force Members, A John Camm, Gregory YH Lip, Raffaele De Caterina, Irene Savelieva, Dan Atar, Stefan H Hohnloser, Gerhard Hindricks, Paulus Kirchhof, ESC Committee for Practice Guidelines (CPG), Jeroen J Bax, Helmut Baumgartner, Claudio Ceconi, Veronica Dean, Christi Deaton, Robert Fagard, Christian Funck-Brentano, David Hasdai, Arno Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Theresa McDonagh, Cyril Moulin, Bogdan A Popescu, Željko Reiner, Udo Sechtem, Per Anton Sirnes, Michal Tendera, Adam Torbicki, Alec Vahanian, Stephan Windecker, Document Reviewers, Panos Vardas, Nawwar Al-Attar, Ottavio Alfieri, Annalisa Angelini, Carina Blömstrom-Lundqvist, Paolo Colonna, Johan De Sutter, Sabine Ernst, Andreas Goette, Bulent Gorenek, Robert Hatala, Hein Heidbüchel, Magnus Heldal, Steen Dalby Kristensen, Philippe Kolh, Jean-Yves Le Heuzey, Hercules Mavrakis, Lluís Mont, Pasquale Perrone Filardi, Piotr Ponikowski, Bernard Prendergast, Frans H Rutten, Ulrich Schotten, Isabelle C Van Gelder, Freek WA Verheugt, None, 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association Europace. ,vol. 14, pp. 1385- 1413 ,(2012) , 10.1093/EUROPACE/EUS305

Stavros Apostolakis, Renee M. Sullivan, Brian Olshansky, Gregory Y.H. Lip, Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin: The SAMe-TT2R2 Score Chest. ,vol. 144, pp. 1555- 1563 ,(2013) , 10.1378/CHEST.13-0054

Giuseppe Boriani, Predicting the Quality of Anticoagulation During Warfarin Therapy: The Basis for an Individualized Approach Chest. ,vol. 144, pp. 1437- 1438 ,(2013) , 10.1378/CHEST.13-1285

Pilar Gallego, Vanessa Roldan, Francisco Marín, Marta Romera, Mariano Valdés, Vicente Vicente, Gregory Y. H. Lip, Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thrombosis and Haemostasis. ,vol. 110, pp. 1189- 1198 ,(2013) , 10.1160/TH13-07-0556

Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, Flemming Skjøth, Karen Margrete Due, Torbjörn Callréus, Mary Rosenzweig, Gregory YH Lip, None, Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study. Journal of the American College of Cardiology. ,vol. 61, pp. 2264- 2273 ,(2013) , 10.1016/J.JACC.2013.03.020

Michael Sharma, Carole Bradley-Kennedy, Andreas Clemens, Brigitta U. Monz, Siyang Peng, Neil Roskell, Sonja V. Sorensen, Anuraag R. Kansal, Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada. Comparative efficacy and cost-effectiveness. Thrombosis and Haemostasis. ,vol. 108, pp. 672- 682 ,(2012) , 10.1160/TH12-06-0388

Christian T Ruff, Robert P Giugliano, Eugene Braunwald, Elaine B Hoffman, Naveen Deenadayalu, Michael D Ezekowitz, A John Camm, Jeffrey I Weitz, Basil S Lewis, Alexander Parkhomenko, Takeshi Yamashita, Elliott M Antman, Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials The Lancet. ,vol. 383, pp. 955- 962 ,(2014) , 10.1016/S0140-6736(13)62343-0